PRESS RELEASE published on 05/25/2023 at 08:00, 1 year 5 months ago Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
PRESS RELEASE published on 05/15/2023 at 08:00, 1 year 6 months ago Biophytis has filed with the EMA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 05/11/2023 at 08:00, 1 year 6 months ago Successful capital increase for Biophytis with €2.3 million raised
PRESS RELEASE published on 05/10/2023 at 19:05, 1 year 6 months ago Biophytis launches a round of fundraising for approximately 2 million euros
PRESS RELEASE published on 05/09/2023 at 08:00, 1 year 6 months ago Biophytis has requested a pre-submission meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the treatment of COVID-19
PRESS RELEASE published on 05/02/2023 at 08:00, 1 year 6 months ago Biophytis strengthens its management team
PRESS RELEASE published on 04/28/2023 at 23:00, 1 year 6 months ago Biophytis announces receipt of Nasdaq Notice
PRESS RELEASE published on 04/19/2023 at 08:00, 1 year 7 months ago Biophytis regains compliance with NASDAQ minimum bid price requirement
PRESS RELEASE published on 04/18/2023 at 08:00, 1 year 7 months ago Biophytis Announces 2022 Financial Results and 2023 Perspectives
PRESS RELEASE published on 04/17/2023 at 23:00, 1 year 7 months ago Biophytis: Results of the Combined General Meeting on April 17, 2023
Published on 11/22/2024 at 00:00, 1 hour 42 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 3 hours 37 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 3 hours 52 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 5 hours 27 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 5 hours 32 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 6 hours 41 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 7 hours 6 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 7 hours 43 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 7 hours 50 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 7 hours 50 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 18 hours 44 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 6 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 7 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 7 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 17 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
